Publication date: Sep 01, 2023
Detection of subgenomic (sg) SARS-CoV-2 RNAs are frequently used as a correlate of viral infectiousness, but few data about correlation between sg load and viable virus are available. Here, we defined concordance between culture isolation and E and N sgRNA quantification by ddPCR assays in 51 nasopharyngeal swabs collected from SARS-CoV-2 positive hospitalized patients. Among the 51 samples, 14 were SARS-CoV-2 culture-positive and 37 were negative. According to culture results, the sensitivity and specificity of E and N sgRNA assays were 100% and 100%, and 84% and 86%, respectively. ROC analysis showed that the best E and N cut-offs to predict positive culture isolation were 32 and 161 copies/mL respectively, with an AUC (95% CI) of 0. 96 (0. 91-1. 00) and 0. 96 (0. 92-1. 00), and a diagnostic accuracy of 88% and 92%, respectively. Even if no significant correlations were observed between sgRNA amount and clinical presentation, a higher number of moderate/severe cases and lower number of days from symptoms onset characterized patients with sgRNA equal to or higher than sgRNA cut-offs. Overall, this study suggests that SARS-CoV-2 sgRNA quantification could be helpful to estimate the replicative activity of SARS-CoV-2 and can represent a valid surrogate marker to efficiently recognize patients with active infection. The inclusion of this assay in available SARS-CoV-2 diagnostics procedure might help in optimizing fragile patients monitoring and management.
Open Access PDF
Concepts | Keywords |
---|---|
Clinical | Assays |
Rnas | Cov |
Virus | Culture |
Cut | |
Isolation | |
Marker | |
Offs | |
Positive | |
Quantification | |
Quantitative | |
Sars | |
Sgrna | |
Subgenomic | |
Surrogate | |
Viral |
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | infectivity |
disease | VO | viable |
drug | DRUGBANK | Saquinavir |
drug | DRUGBANK | Aspartame |
disease | MESH | infection |
disease | IDO | assay |
disease | MESH | Infectious Diseases |
disease | IDO | history |
disease | IDO | process |
pathway | REACTOME | Reproduction |
disease | VO | time |
drug | DRUGBANK | Nonoxynol-9 |
drug | DRUGBANK | Gold |
pathway | KEGG | Viral replication |
disease | IDO | replication |
disease | IDO | production |
disease | VO | population |
disease | MESH | viral shedding |
disease | MESH | COVID 19 |
disease | VO | protocol |
pathway | KEGG | RNA polymerase |
drug | DRUGBANK | Creatinolfosfate |
drug | DRUGBANK | Indoleacetic acid |
drug | DRUGBANK | Medical air |
drug | DRUGBANK | Streptomycin |
drug | DRUGBANK | L-Glutamine |
drug | DRUGBANK | Trypsin |
disease | VO | gene |